Article

HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.

Department of Cardiothoracic, Transplantation, and Vascular Surgery, Hannover Medical School, Hannover, Germany.
The Annals of thoracic surgery (impact factor: 3.74). 09/2009; 88(2):674-5. DOI:10.1016/j.athoracsur.2008.12.090 pp.674-5
Source: PubMed

ABSTRACT Diverse anticoagulation protocols are used in patients after implantation of ventricular assist devices. No consensus exists, especially in patients with heparin-induced thrombocytopenia type II. In a patient with heparin-induced thrombocytopenia type II, we implanted a left ventricular assist device (HeartMate XVE; Thoratec, Pleasanton, CA). Thirteen months later the device had to be replaced due to mechanical failure with a HeartMate II left ventricular assist device. We report on our successful protocol of perioperative anticoagulation management using heparin and iloprost during surgery and argatroban thereafter.

0 0
 · 
0 Bookmarks
 · 
44 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

argatroban
 
CA
 
devices
 
Diverse anticoagulation protocols
 
HeartMate XVE
 
heparin
 
heparin-induced thrombocytopenia type II
 
left ventricular
 
mechanical failure
 
perioperative anticoagulation management
 
successful protocol
 
Thoratec